🔎 Trials Near Me

Dachaigh › Galar cealla corraich › New York › New York City

Sgrùdaidhean clionaigeach Galar cealla corraich ann an New York City, NY

Tha 13 sgrùdaidhean airson Galar cealla corraich a’ lorg phàirtichean aig làraichean ann agus timcheall air New York City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

A’ fastadhÌre 1
  • Mount Sinai Hospital, New York
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

A’ fastadhÌre 3
  • Columbia University Medical Center_New York_0, New York
  • Columbia University Medical Center_New York_0, New York
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06609226

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

A’ fastadhÌre 2/3
  • Icahn School of Medicine at Mount Sinai, New York
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

A’ fastadhSgrùdadh amharc
  • Weill Cornell Medical College - New York Presbyterian Hospital, New York
Gach aois · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

A’ fastadhÌre 2
  • Mount Sinai Medical Center, New York
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT06699849

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

A’ fastadhÌre 1/2
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering, New York
Aoisean 12 gu 50 · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT04819841

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

A’ fastadhÌre 1
  • Columbia University Irving Medical Center, New York
Aoisean 12 gu 50 · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT07015684

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

A’ fastadhSgrùdadh amharc
  • Columbia Presbytarian (NT-DMT), New York
Aoisean 3 gu 20 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06941389

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

A’ fastadhÌre 3
  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Aoisean 12 gu 35 · Gach gnè · Air ùrachadh 23 Màrt 2026 · NCT05477563

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

A’ fastadhÌre 2
  • Columbia University, New York
Aoisean 2 gu 25 · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT03587272

A Long-term Follow-up Study in Patients Who Received BEAM-101

A’ fastadhSgrùdadh amharc
  • Columbia University Irving Medical Center, New York
Aoisean 14 gu 37 · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT07373639

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

A’ fastadh
  • Weil Cornell Medical College, New York
Aoisean 16 gu 30 · Gach gnè · Air ùrachadh 7 Faoi 2026 · NCT06374238

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

A’ fastadhÌre 2
  • Mount Sinai Hospital, New York
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2025 · NCT05519111

Sgrùdaidhean Galar cealla corraich ann am bailtean eile

Sgrùdaidhean eile ann an New York City

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.